WallStreetZenWallStreetZen

NASDAQ: EMBC
Embecta Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

EMBC past earnings growth

How has EMBC's earnings growth performed historically?
Company
-66.08%
Industry
27.37%
Market
104.85%
EMBC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
EMBC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

EMBC past revenue growth

How has EMBC's revenue growth performed historically?
Company
0.58%
Industry
7.76%
Market
17.15%
EMBC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EMBC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EMBC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EMBC earnings and revenue history

Current Revenue
$1.1B
Current Earnings
$55.3M
Current Profit Margin
4.9%

EMBC Return on Equity

Current Company
-6.8%
Current Industry
11.1%
Current Market
188%
EMBC's Return on Equity (-6.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EMBC announces earnings.

EMBC Return on Assets

Current Company
4.5%
Current Industry
7.2%
EMBC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EMBC Return on Capital Employed

Current Company
19.41%
Current Industry
9.7%

EMBC vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EMBC$1.12B$207.60M$55.30M-2.03%-63.46%
ZJYLN/AN/AN/AN/AN/A
ATRI$169.33M$37.62M$19.41M+2.12%-9.83%
BLFS$143.27M-$51.75M-$66.43M+48.65%N/A
PLSE$0.00-$42.37M-$42.21M-100.00%N/A
View Top Medical Stocks

EMBC earnings dates

Next earnings date
May 10, 2024

Embecta Earnings & Revenue FAQ

What were EMBC's earnings last quarter?

On Invalid Date, Embecta (NASDAQ: EMBC) reported Q4 2023 earnings per share (EPS) of $0.35, up 43.55% year over year. Total Embecta earnings for the quarter were $20.10 million. In the same quarter last year, Embecta's earnings per share (EPS) was $0.62.

If you're new to stock investing, here's how to buy Embecta stock.

What was EMBC's earnings growth in the past year?

As of Q2 2024, Embecta's earnings has grown -66.08% year over year. This is 93.45 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.37%. Embecta's earnings in the past year totalled $55.30 million.

What is EMBC's earnings date?

Embecta's earnings date is Invalid Date. Add EMBC to your watchlist to be reminded of EMBC's next earnings announcement.

What was EMBC's revenue last quarter?

On Invalid Date, Embecta (NASDAQ: EMBC) reported Q4 2023 revenue of $277.30 million up 0.58% year over year. In the same quarter last year, Embecta's revenue was $275.70 million.

What was EMBC's revenue growth in the past year?

As of Q2 2024, Embecta's revenue has grown 0.58% year over year. This is 7.18 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.76%. Embecta's revenue in the past year totalled $1.12 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.